Office of Janssen Pharmaceuticals, part of Johnson & Johnson, at the Leiden Bio Science Park in the Netherlands. Photo: Shutterstock
The Pennsylvania Supreme Court on Thursday probed into questions about what level of public awareness regarding the dangers of a widely used pharmaceutical can sufficiently put potential plaintiffs on notice to investigate their claims.
May 16, 2019 at 04:11 PM
1 minute read
Bureau Chief
The Pennsylvania Supreme Court on Thursday probed into questions about what level of public awareness regarding the dangers of a widely used pharmaceutical can sufficiently put potential plaintiffs on notice to investigate their claims.
According to an attorney representing two men alleging to have been injured by the antipsychotic drug Risperdal, the level of public awareness needs to reach as far as coverage in small-town newspapers.
Deal Watch: Skadden, Sidley, Slaughter and S&C Lead Big Paper Deal, While Private Funds Grow Massive
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
